Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Kidney Disease Clinical Trials

A listing of Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (125) clinical trials

Iron deficiency anemia is a type of anemia that commonly occurs after significant blood loss from a disease or medical condition. The loss of iron means your body can't carry enough oxygen, which often leaves you tired and breathless. In this study participants who have been diagnosed with chronic kidney ...

Phase

A Multicenter, Randomized, Open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD Qualified Participants will receive at no cost to them. Study Medication Study Related Labs Physical Exams Rescue Medication Compensation for your time and travel for each completed study visit To Lean More ...

Phase

What are the FIDELIO-DKD and FIGARO-DKD studies? The FIDELIO-DKD and FIGARO-DKD studies are clinical research studies for adults with type 2 diabetes and diabetic kidney disease (DKD). The purpose of the studies is to evaluate whether adding an investigational medication to regular treatment may be safe and effective to help ...

Phase

Wat zijn de FIDELIO-DKD- en FIGARO-DKD-studies? De FIDELIO-DKD- en FIGARO-DKD-studies zijn klinisch-wetenschappelijke studies voor volwassenen met type 2-diabetes en diabetische nierziekte (DKD). Het doel van de studies is te evalueren of de toevoeging van een experimenteel geneesmiddel aan de standaardbehandeling veilig en doeltreffend is om de progressie van nierziekte bij patiënten ...

Phase

¿Qué son los estudios FIDELIO-DKD y FIGARO-DKD? Los estudios de investigación clínica FIDELIO-DKD y FIGARO-DKD son para adultos con diabetes tipo 2 y nefropatía diabética (NPD). El objetivo de estos estudios es evaluar si el hecho de agregar un medicamento en fase de investigación al tratamiento habitual puede ayudar de ...

Phase

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.

Phase

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.

Phase

Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)

Acute kidney injury (AKI) is a common and devastating complication of critical illness. Once AKI is established, treatment is largely supportive and no intervention has been found to restore kidney function or improve overall survival. Renal replacement therapy (RRT), usually in the form of hemodialysis, is frequently needed to manage ...

Phase

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant

This is a Phase 3 randomized, placebo-controlled, double-blind, multi-center trial stratified by donor age and by region to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from DBD donors who were at least 45 years of age.

Phase

A Randomized Double-blind Active Control Parallel Group Titration Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

The randomized subjects will take the investigational product (Fimasartan or Losartan) corresponding to each treatment group for 24 weeks. After that, all subjects will take Fimasartan for additional 120 weeks in an open-label, 2-parallel group study conducted with 2 groups in accordance with the blood pressure control criteria.

Phase